AAAAAA

   
Results: 1-13 |
Results: 13
Predictive process simulation and stress-mediated diffusion in silicon
Authors: Windl, W Laudon, M Carlson, NN Daw, MS
Citation: W. Windl et al., Predictive process simulation and stress-mediated diffusion in silicon, COMPUT SC E, 3(4), 2001, pp. 92-95
Effect of stress on dopant and defect diffusion in Si: A general treatment- art. no. 045205
Authors: Daw, MS Windl, W Carlson, NN Laudon, M Masquelier, MP
Citation: Ms. Daw et al., Effect of stress on dopant and defect diffusion in Si: A general treatment- art. no. 045205, PHYS REV B, 6404(4), 2001, pp. 5205
Melatonin production in healthy infants: Evidence for seasonal variations
Authors: Sivan, Y Laudon, M Tauman, R Zisapel, N
Citation: Y. Sivan et al., Melatonin production in healthy infants: Evidence for seasonal variations, PEDIAT RES, 49(1), 2001, pp. 63-68
Melatonin treatment for tardive dyskinesia - A double-blind, placebo-controlled, crossover study
Authors: Shamir, E Barak, Y Shalman, I Laudon, M Zisapel, N Tarrasch, R Elizur, A Weizman, R
Citation: E. Shamir et al., Melatonin treatment for tardive dyskinesia - A double-blind, placebo-controlled, crossover study, ARCH G PSYC, 58(11), 2001, pp. 1049-1052
Multiscale modeling of stress-mediated diffusion in silicon: Ab initio to continuum
Authors: Laudon, M Carlson, NN Masquelier, MP Daw, MS Windl, W
Citation: M. Laudon et al., Multiscale modeling of stress-mediated diffusion in silicon: Ab initio to continuum, APPL PHYS L, 78(2), 2001, pp. 201-203
Clinical trials of controlled-release melatonin in children with sleep-wake cycle disorders
Authors: Jan, JE Hamilton, D Seward, N Fast, DK Freeman, RD Laudon, M
Citation: Je. Jan et al., Clinical trials of controlled-release melatonin in children with sleep-wake cycle disorders, J PINEAL R, 29(1), 2000, pp. 34-39
First-night effect of melatonin treatment in patients with chronic schizophrenia
Authors: Shamir, E Rotenberg, VS Laudon, M Zisapel, N Elizur, A
Citation: E. Shamir et al., First-night effect of melatonin treatment in patients with chronic schizophrenia, J CL PSYCH, 20(6), 2000, pp. 691-694
Melatonin improves sleep quality of patients with chronic schizophrenia
Authors: Shamir, E Laudon, M Barak, Y Anis, Y Rotenberg, V Elizur, A Zisapel, N
Citation: E. Shamir et al., Melatonin improves sleep quality of patients with chronic schizophrenia, J CLIN PSY, 61(5), 2000, pp. 373-377
Low melatonin production in infants with a life-threatening event
Authors: Sivan, Y Laudon, M Kuint, J Zisapel, N
Citation: Y. Sivan et al., Low melatonin production in infants with a life-threatening event, DEVELOP MED, 42(7), 2000, pp. 487-491
Thermally actuated optical microscanner with large angle and low consumption
Authors: Schweizer, S Calmes, S Laudon, M Renaud, P
Citation: S. Schweizer et al., Thermally actuated optical microscanner with large angle and low consumption, SENS ACTU-A, 76(1-3), 1999, pp. 470-477
Melatonin treatment of non-epileptic myoclonus in children
Authors: Jan, JE Connolly, MBC Hamilton, D Freeman, RD Laudon, M
Citation: Je. Jan et al., Melatonin treatment of non-epileptic myoclonus in children, DEVELOP MED, 41(4), 1999, pp. 255-259
Facilitation of benzodiazepine discontinuation by melatonin - A new clinical approach
Authors: Garfinkel, D Zisapel, N Wainstein, J Laudon, M
Citation: D. Garfinkel et al., Facilitation of benzodiazepine discontinuation by melatonin - A new clinical approach, ARCH IN MED, 159(20), 1999, pp. 2456-2460
Long-term results of cancer immunotherapy with subcutaneous low-dose interleukin-2 plus melatonin
Authors: Lissoni, P Laudon, M Barni, S Brivio, F Tisi, E Rovelli, F Chatikhine, V Fumagalli, L Maestroni, GJM Conti, A Tancini, G
Citation: P. Lissoni et al., Long-term results of cancer immunotherapy with subcutaneous low-dose interleukin-2 plus melatonin, INT J IMM T, 14(3), 1998, pp. 169-174
Risultati: 1-13 |